Tablet Formulations of Polymeric Electrospun Fibers for the Controlled Release of Drugs with pH-Dependent Solubility.
fast release
formulation
nanofibers
polymer
poorly soluble drug
release kinetics
sustained release
tablets
Journal
Polymers
ISSN: 2073-4360
Titre abrégé: Polymers (Basel)
Pays: Switzerland
ID NLM: 101545357
Informations de publication
Date de publication:
23 May 2022
23 May 2022
Historique:
received:
28
04
2022
revised:
18
05
2022
accepted:
21
05
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
29
5
2022
Statut:
epublish
Résumé
A challenge in the pharmaceutical sector is the development of controlled release dosage forms for oral administration of poorly soluble drugs, in particular, drugs characterized by pH-dependent solubility through the gastrointestinal tract, which itself shows wide variability in terms of environmental pHs. The best approach is to increase the dissolution rate of the drugs at the different pHs and only then modify its release behavior from the pharmaceutical form. This work aims to demonstrate the ability of properly designed polymeric nanofibers in enhancing the release rate of model drugs with different pH-dependent solubility in the different physiological pHs of the gastrointestinal tract. Polymeric nanofibers loaded with meloxicam and carvedilol were prepared using the electrospinning technique and were then included in properly designed tablet formulations to obtain fast or sustained release dosage forms. The nanofibers and the tablets were characterized for their morphological, physico-chemical and dissolution properties. The tablets are able to deliver the dose according to the expected release behavior, and zero-order, first-order, Higuchi, Korsmeyer-Peppas and Hixon-Crowell kinetics models were used to analyze the prevailing release mechanism of the tablets. This study shows that the electrospun fibers can be advantageously included in oral dosage forms to improve their release performances.
Identifiants
pubmed: 35632009
pii: polym14102127
doi: 10.3390/polym14102127
pmc: PMC9142934
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Pharmaceutics. 2020 Apr 25;12(5):
pubmed: 32344802
Pharmaceutics. 2019 Nov 20;11(12):
pubmed: 31757093
J Pharm Pharmacol. 2005 May;57(5):533-46
pubmed: 15901342
Biomaterials. 2015 Aug;61:327-38
pubmed: 26043061
Curr Drug Deliv. 2019;16(4):272-294
pubmed: 30674256
Int J Pharm. 2011 Oct 10;418(1):6-12
pubmed: 21458553
Colloids Surf B Biointerfaces. 2021 Aug;204:111819
pubmed: 33964528
Life Sci. 2004 Jan 2;74(7):873-84
pubmed: 14659976
Int J Pharm. 2007 Mar 21;333(1-2):136-42
pubmed: 17207943
Drug Dev Ind Pharm. 2004 Jan;30(1):9-17
pubmed: 15000425
J Pharm Sci. 2019 Apr;108(4):1529-1539
pubmed: 30476510
Mater Sci Eng C Mater Biol Appl. 2021 Jan;120:111698
pubmed: 33545857
Drug Discov Today Technol. 2012 Summer;9(2):e71-e174
pubmed: 24064267
Int J Pharm. 2016 Sep 10;511(1):190-197
pubmed: 27418562
Int J Biol Macromol. 2013 Nov;62:472-80
pubmed: 24076034
Int J Mol Sci. 2019 Jun 24;20(12):
pubmed: 31238568
Mater Sci Eng C Mater Biol Appl. 2020 Jul;112:110928
pubmed: 32409077
Expert Opin Drug Deliv. 2015;12(9):1547-63
pubmed: 25943722
J Mech Behav Biomed Mater. 2020 Apr;104:103696
pubmed: 32174438
Expert Opin Drug Deliv. 2018 Jan;15(1):65-75
pubmed: 28662354
J Pharm Biomed Anal. 2014 Aug 5;96:10-20
pubmed: 24705456
Carbohydr Polym. 2017 May 15;164:339-348
pubmed: 28325334
Int J Mol Sci. 2010 Sep 15;11(9):3298-322
pubmed: 20957095
Pharmaceuticals (Basel). 2021 Mar 25;14(4):
pubmed: 33806015
Curr Drug Deliv. 2018;15(10):1360-1374
pubmed: 30033869
J Control Release. 2020 Nov 10;327:834-856
pubmed: 32931897
Pharmaceutics. 2019 Apr 03;11(4):
pubmed: 30987212